Achieve Life Sciences Management
Management criteria checks 1/4
Achieve Life Sciences' CEO is Rick Stewart, appointed in Aug 2024, has a tenure of 1.33 years. total yearly compensation is $1.74M, comprised of 29.4% salary and 70.6% bonuses, including company stock and options. directly owns 0.43% of the company’s shares, worth $1.08M. The average tenure of the management team and the board of directors is 1.1 years and 2.8 years respectively.
Key information
Rick Stewart
Chief executive officer
US$1.7m
Total compensation
| CEO salary percentage | 29.38% |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.4% |
| Management average tenure | 1.1yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
Achieve Life Sciences: FDA Approval Not Assured, But Valuation Justifies Risk
Jun 03Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?
Feb 15
Achieve Life Sciences: 1st Half 2025 NDA Filing On Track With FDA Agreement
Jul 01Does Achieve Life Sciences (NASDAQ:ACHV) Have A Healthy Balance Sheet?
Jan 27Is Achieve Life Sciences (NASDAQ:ACHV) Using Debt In A Risky Way?
Oct 26Is Achieve Life Sciences (NASDAQ:ACHV) A Risky Investment?
Mar 26CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -US$52m |
| Jun 30 2025 | n/a | n/a | -US$50m |
| Mar 31 2025 | n/a | n/a | -US$46m |
| Dec 31 2024 | US$2m | US$510k | -US$40m |
| Sep 30 2024 | n/a | n/a | -US$33m |
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$27m |
| Dec 31 2023 | US$1m | US$450k | -US$30m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$42m |
| Mar 31 2023 | n/a | n/a | -US$44m |
| Dec 31 2022 | US$1m | US$400k | -US$42m |
| Sep 30 2022 | n/a | n/a | -US$38m |
| Jun 30 2022 | n/a | n/a | -US$32m |
| Mar 31 2022 | n/a | n/a | -US$33m |
| Dec 31 2021 | US$1m | US$400k | -US$33m |
| Sep 30 2021 | n/a | n/a | -US$31m |
| Jun 30 2021 | n/a | n/a | -US$28m |
| Mar 31 2021 | n/a | n/a | -US$19m |
| Dec 31 2020 | US$1m | US$474k | -US$15m |
| Sep 30 2020 | n/a | n/a | -US$13m |
| Jun 30 2020 | n/a | n/a | -US$13m |
| Mar 31 2020 | n/a | n/a | -US$14m |
| Dec 31 2019 | US$797k | US$500k | -US$16m |
Compensation vs Market: Rick's total compensation ($USD1.74M) is about average for companies of similar size in the US market ($USD1.44M).
Compensation vs Earnings: Rick's compensation has increased whilst the company is unprofitable.
CEO
Rick Stewart (66 yo)
Dr. Richard A. B. Stewart, also known as Rick, serves as President at Achieve Life Sciences, Inc. from December 2025. He had been an Executive Chairman at Achieve Life Sciences, Inc. since September 28, 20...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.3yrs | US$1.74m | 0.43% $ 1.1m | |
| Chief Financial Officer | 1yr | US$1.41m | 0.24% $ 601.3k | |
| Chief Operations Officer | less than a year | no data | 0.098% $ 246.1k | |
| VP of Finance & Principal Accounting Officer | no data | no data | 0.061% $ 153.7k | |
| Chief Legal Officer | less than a year | no data | no data | |
| Chief Commercial Officer | 8.9yrs | no data | 0.14% $ 349.8k | |
| Interim Chief Medical Officer | 1.2yrs | no data | no data | |
| Vice President of Strategic Communications & Stakeholder Relations | no data | no data | no data |
Experienced Management: ACHV's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 8.9yrs | US$1.74m | 0.43% $ 1.1m | |
| Independent Chairman | 2.8yrs | US$154.50k | 0.59% $ 1.5m | |
| Independent Director | 2.8yrs | US$162.88k | 0% $ 0 | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Independent Director | 2.8yrs | US$163.85k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$164.38k | 0% $ 0 | |
| Independent Director | less than a year | no data | 0% $ 0 |
Experienced Board: ACHV's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/31 07:17 |
| End of Day Share Price | 2025/12/31 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Achieve Life Sciences, Inc. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | CG Capital |
| Gary Nachman | CGS International |
| Jason Butler | Citizens JMP Securities, LLC |